Inflammopharmacology
SARS-CoV-2 infection and gut-lung axis: the potential role of rifaximin.
Taghreed N Almanaa, Hayder M Al-Kuraishy, Ali I Al-Gareeb, Maii A Abdelnaby, Athanasios Alexiou, Marios Papadakis, Islam E Abo-ElFetoh, Gaber El-Saber Batiha
Published: 202510.1007/s10787-025-02082-5
Abstract
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), leading to global effects. COVID-19 causes pulmonary and extra-pulmonary manifestations. One of the most common extra-pulmonary manifestati…
Preview only. Read the full abstract at the source